Results
blood [HCONo gastrointestinal symptoms
The peak [HCOIndividual time to peak and mean (± SD) metabolite responses to 0.3 g·kgTime to Peak(min)Mean ± SD 2 km TT performance time (During the time trials, the ingestion of SB resulted in significantly altered blood [HCOMean ± SD blood [HCONo gastrointestinal symptoms were observed either prior to ingestion in any of the trials, or at any point throughout the FAM trials. Some GI symptoms were reported in both the PLA and the SB trials, but the frequency of the symptom reports (Table Individual GI symptom scores immediately pre-exercise. Recorded symptoms are displayed in bold, and scores are displayed in parentheses